Cellectis (CLLS) Common Equity (2014 - 2026)
Cellectis (CLLS) recorded Common Equity of $41.07 million in Q2 2026, down 57.7% from $97.11 million a year earlier and down 31.5% from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) Common Equity (2014 - 2026) Analysis & Trends
At the end of FY2025, Cellectis reported Common Equity of $75.9 million, down 42.1% from FY2024.
- Annual Common Equity has a five-year compound annual growth rate of -24.5% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $131.03 million in FY2024 (+54.7%), $84.7 million in FY2023 (-32.8%), $125.94 million in FY2022 (-46.7%) and $236.47 million in FY2021 (-23.4%).
- The Q2 2026 figure is the lowest quarterly Common Equity in data going back to Q4 2014.
- On a year-over-year basis, Common Equity has declined for five consecutive quarters, with an average decline of 6.5% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 70.0% in Q3 2024, against a decline of 57.7% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $59.92 million (Q1 2026), $75.9 million (Q4 2025) and $100.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Cellectis | 148.50 Mn | -604.89 Mn | - | 41.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.07 Mn |
| Mar 31, 2026 | 59.92 Mn |
| Dec 31, 2025 | 75.90 Mn |
| Sep 30, 2025 | 100.48 Mn |
| Jun 30, 2025 | 97.11 Mn |
| Mar 31, 2025 | 116.20 Mn |
| Dec 31, 2024 | 131.03 Mn |
| Sep 30, 2024 | 129.42 Mn |
| Jun 30, 2024 | 148.61 Mn |
| Mar 31, 2024 | 90.57 Mn |
| Dec 31, 2023 | 84.70 Mn |
| Sep 30, 2023 | 76.12 Mn |
| Jun 30, 2023 | 96.56 Mn |
| Mar 31, 2023 | 120.49 Mn |
| Dec 31, 2022 | 125.94 Mn |
| Sep 30, 2022 | 145.61 Mn |
| Jun 30, 2022 | 180.52 Mn |
| Mar 31, 2022 | 203.05 Mn |
| Dec 31, 2021 | 236.47 Mn |
| Sep 30, 2021 | 262.15 Mn |
API Access
Cellectis Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();